ARBITER-2: judging the next step in lipid management

Br J Cardiol 2005;12:9-10 Leave a comment
Click any image to enlarge
Authors:

Statin therapy is established as the basis of lipid-lowering
therapy in all patients with established atherosclerotic
disease.1 However, statin trials show that 50–70% of
cardiovascular events cannot be prevented by statins alone.2,3
This raises the question about the next step that should be
taken to prevent further events in high-risk patients already
on a statin.ITED

Advertisement
Heart failure - BJC Learning programme
For healthcare professionals only

THERE ARE CURRENTLY NO COMMENTS FOR THIS ARTICLE - LEAVE A COMMENT